Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZNHIT3 Inhibitors

ZNHIT3 inhibitors are a specialized class of chemical compounds that target and inhibit the activity of the ZNHIT3 protein. ZNHIT3, or Zinc Finger HIT-Type Containing 3, is a zinc-binding protein involved in various cellular processes, including chromatin remodeling, gene expression, and protein-protein interactions. The inhibition of ZNHIT3 can influence the assembly and regulation of macromolecular complexes, particularly those involved in histone modification. This protein's zinc finger motif is critical for its ability to bind to DNA and other proteins, acting as a mediator in epigenetic regulation. ZNHIT3 inhibitors, therefore, are designed to disrupt this binding capacity, leading to alterations in the dynamic structure of chromatin and, ultimately, influencing the transcriptional activity of certain genes.

On a molecular level, ZNHIT3 inhibitors are structured to bind specifically to the active site or the zinc finger domain of the protein. By preventing proper zinc ion coordination or blocking key interaction sites, these inhibitors can induce conformational changes that destabilize the protein's function. The chemical composition of ZNHIT3 inhibitors is often characterized by high affinity for zinc-binding motifs and precise targeting of the protein's interaction networks. These inhibitors are valuable tools in molecular biology research as they enable scientists to study the functional role of ZNHIT3 in chromatin regulation, cell cycle control, and its broader role in the maintenance of genomic stability. Through the application of ZNHIT3 inhibitors, researchers can better understand the underlying mechanisms governing gene expression and protein dynamics in various biological systems.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR pathway, which can regulate the assembly of multi-protein complexes that ZNHIT3 may be a part of.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Histone deacetylase inhibitor that can alter chromatin structure, potentially affecting ZNHIT3 binding affinity.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

DNA methyltransferase inhibitor that can change gene expression, possibly altering ZNHIT3 function.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor that can increase cellular protein levels, including proteins that interact with ZNHIT3.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Lysosomotropic agent that can alter autophagic processes, indirectly affecting ZNHIT3-related pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor that can affect MAPK/ERK pathway, potentially influencing ZNHIT3 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor that can impact AKT signaling, potentially modulating ZNHIT3's role in cellular processes.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor that can interfere with stress response pathways, possibly affecting ZNHIT3's function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that can affect AP-1 transcription factor activity, potentially influencing ZNHIT3.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor that can perturb protein degradation pathways, indirectly impacting ZNHIT3.